Nox Mobility | $2,341,030 | (Apr 23, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)
Mosaic(US) | $18,000,000 | (Apr 23, 2026)
Evozyne
United States
- Chicago, IL
- 28/09/2023
- Series B
- $81,000,000
Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.
- Industry Biotechnology
- Website https://www.evozyne.com/
- LinkedIn https://www.linkedin.com/company/evozyne/about/
Related People
Mike GamsonFounder
United States -
Greater Chicago Area
I'm passionate about leading teams to pursue inspiring goals. I love working with intellectually curious people who can do anything, but show up everyday with humility and a drive to be better than they were yesterday. I believe that driving results matters as does taking the time in life to stop to smell the roses. I aspire to be a great colleague and I hope to be a student of new things forever.
Omeza | $8,500,000 | (Apr 23, 2026)
Calibre | $3,300,000 | (Apr 23, 2026)
BuildForever | $9,500,000 | (Apr 23, 2026)
10x Science (YC W26) | $4,800,000 | (Apr 23, 2026)
Schematic | $6,500,000 | (Apr 23, 2026)
Crewline | $7,100,000 | (Apr 23, 2026)
Monk | $25,000,000 | (Apr 22, 2026)
NeoCognition | $40,000,000 | (Apr 22, 2026)
Qualitate | $7,000,000 | (Apr 22, 2026)